The EIB and Utrecht-based AM-Pharma have signed a €24 million financing agreement. The funds will be used to accelerate the development of the clinical stage biopharmaceutical company’s recombinant alkaline phosphatase enzyme, which is used to treat acute kidney injury (AKI). The...
David Havlíček, CEO of EGAP, the Czech Republic’s export credit agency, discusses the fast evolution of the ECAs’ activity and the pilot plan with the European Investment Bank...
Europe drove overall export finance growth in 2025. But ECAs look set to up support to emerging markets.
The financial fallout from NewSat's failed Jabiru-1 satellite project financing could be stratospheric. Investors are claiming $1 billion or more in damages from banks as part of an ongoing lawsuit – but why did lenders and ECAs struggle to find a default cure?
David Havlíček, CEO of EGAP, the Czech Republic’s export credit agency, discusses the fast evolution of the ECAs’ activity and the pilot plan with the European Investment Bank that could help boost ECA capacity. Could it scale? He also discusses the extension of guarantee coverage to local suppliers in domestic projects that will facilitate nuclear infrastructure in particular. Hear more when EGAP hosts our global event in Prague in June.
Europe drove overall export finance growth in 2025. But ECAs look set to up support to emerging markets.
Unveil Amsterdam's allure! Elevate your pipeline with top dealmakers. An Industry Awards dinner adds glamour to this unmissable adventure.
View more
Propel Your Career Forward with the Gold Standard in ECA Finance Education
View more